3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
10
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
2
magrolimab
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Whole-Body Irradiation
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Daunorubicin
1
Cytarabine
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
CPX-351
1
Busulfan
1
ASTX029
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Anemia, Refractory, with Excess of Blasts
×
Daunorubicin
×
Clear all
NCT05829434
2024-02-12
MAGROLIC
University of Leipzig
Phase 2
Withdrawn